Literature DB >> 16455315

Prediction of the binding mode between BMS-378806 and HIV-1 gp120 by docking and molecular dynamics simulation.

Ren Kong1, Jian Jun Tan, Xiao Hui Ma, Wei Zu Chen, Cun Xin Wang.   

Abstract

BMS-378806 is a newly discovered small molecule that effectively blocks the binding of CD4 with gp120. The binding mode of this kind of inhibitor remains unknown. In this paper, AutoDock 3.0 in conjunction with molecular dynamics simulation, accommodating the receptor's flexibility, was used to explore the binding mode between BMS-378806 and gp120. Two structures, Mode I and Mode II, with the lowest docking energy were selected as different representative binding modes. The analysis of the results from the molecular dynamics simulation indicated that the binding of BMS-348806 in Mode II is more stable. The average structure of Mode II was analyzed and compared with the experimental data. The conclusion was that BMS-378806 inserts the azaindole ring deeply into the PHE43 cavity and makes contact with a number of residues in the cavity, on the cavity and near the cavity. This study benefits the understanding of the mechanism of this kind of inhibitor and may provide useful information for rational drug design.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455315     DOI: 10.1016/j.bbapap.2005.12.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  Anti-HIV drug development through computational methods.

Authors:  Wan-Gang Gu; Xuan Zhang; Jun-Fa Yuan
Journal:  AAPS J       Date:  2014-04-24       Impact factor: 4.009

2.  Illuminating HIV gp120-Ligand Recognition through Computationally-Driven Optimization of Antibody-Recruiting Molecules.

Authors:  Christopher G Parker; Markus K Dahlgren; Ran N Tao; Don T Li; Eugene F Douglass; Takuji Shoda; Navneet Jawanda; Krasimir A Spasov; Sangil Lee; Nannan Zhou; Robert A Domaoal; Richard E Sutton; Karen S Anderson; William L Jorgensen; Mark Krystal; David A Spiegel
Journal:  Chem Sci       Date:  2014-06-01       Impact factor: 9.825

3.  Tetrahydrocurcumin-loaded vaginal nanomicrobicide for prophylaxis of HIV/AIDS: in silico study, formulation development, and in vitro evaluation.

Authors:  Amit Mirani; Harish Kundaikar; Shilpa Velhal; Vainav Patel; Atmaram Bandivdekar; Mariam Degani; Vandana Patravale
Journal:  Drug Deliv Transl Res       Date:  2019-08       Impact factor: 4.617

4.  An antibody-recruiting small molecule that targets HIV gp120.

Authors:  Christopher G Parker; Robert A Domaoal; Karen S Anderson; David A Spiegel
Journal:  J Am Chem Soc       Date:  2009-11-18       Impact factor: 15.419

Review 5.  Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection.

Authors:  Jian J Tan; Xiao J Cong; Li M Hu; Cun X Wang; Lee Jia; Xing-Jie Liang
Journal:  Drug Discov Today       Date:  2010-01-22       Impact factor: 7.851

6.  The investigations on HIV-1 gp120 bound with BMS-488043 by using docking and molecular dynamics simulations.

Authors:  Liang Li; Hang Chen; Run-Ning Zhao; Ju-Guang Han
Journal:  J Mol Model       Date:  2012-10-20       Impact factor: 1.810

Review 7.  Small Molecule HIV-1 Attachment Inhibitors: Discovery, Mode of Action and Structural Basis of Inhibition.

Authors:  Yen-Ting Lai
Journal:  Viruses       Date:  2021-05-06       Impact factor: 5.048

8.  Systematic protein-protein docking and molecular dynamics studies of HIV-1 gp120 and CD4: insights for new drug development.

Authors:  T Chong Teoh; T Heidelberg; M Rizman-Idid
Journal:  Daru       Date:  2011       Impact factor: 3.117

9.  Substrate recognition and motion mode analyses of PFV integrase in complex with viral DNA via coarse-grained models.

Authors:  Jianping Hu; Ming Liu; Dianyong Tang; Shan Chang
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

10.  The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.

Authors:  Fiorella Rossi; Bianca Querido; Manideepthi Nimmagadda; Simon Cocklin; Sonia Navas-Martín; Julio Martín-García
Journal:  Retrovirology       Date:  2008-10-06       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.